Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.53p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.00
  • 52 Week Low: 0.42
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 611,194
  • Market Cap: £1.97m
  • RiskGrade: 435

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
94.70% above the market average94.70% above the market average94.70% above the market average94.70% above the market average94.70% above the market average
85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average85.19% above the sector average
Price Book Ratio
53.11% above the market average53.11% above the market average53.11% above the market average53.11% above the market average53.11% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
0.58% above the market average0.58% above the market average0.58% above the market average0.58% above the market average0.58% above the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average
Price Chg 3m
60.93% below the market average60.93% below the market average60.93% below the market average60.93% below the market average60.93% below the market average
23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
9.08% below the market average9.08% below the market average9.08% below the market average9.08% below the market average9.08% below the market average
2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average2.33% above the sector average
Momentum 20
33.91% below the market average33.91% below the market average33.91% below the market average33.91% below the market average33.91% below the market average
20.93% below the sector average20.93% below the sector average20.93% below the sector average20.93% below the sector average20.93% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
99% below the market average99% below the market average99% below the market average99% below the market average99% below the market average
94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
65.46% below the market average65.46% below the market average65.46% below the market average65.46% below the market average65.46% below the market average
31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.84% below the market average97.84% below the market average97.84% below the market average97.84% below the market average97.84% below the market average
88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average88.24% below the sector average
Operating Profit Loss
58.33% below the market average58.33% below the market average58.33% below the market average58.33% below the market average58.33% below the market average
14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
89.1% below the market average89.1% below the market average89.1% below the market average89.1% below the market average89.1% below the market average
82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average
Cash
85.69% below the market average85.69% below the market average85.69% below the market average85.69% below the market average85.69% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.53p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.00
52 Week Low 0.42
Volume 611,194
Shares Issued 374.35m
Market Cap £1.97m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.74% above the market average20.74% above the market average20.74% above the market average20.74% above the market average20.74% above the market average
40.43% above the sector average40.43% above the sector average40.43% above the sector average40.43% above the sector average40.43% above the sector average
Price Trend
96.37% below the market average96.37% below the market average96.37% below the market average96.37% below the market average96.37% below the market average
95.74% below the sector average95.74% below the sector average95.74% below the sector average95.74% below the sector average95.74% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 16-May-2025

Time Volume / Share Price
16:13 38,000 @ 0.55p
16:04 44,729 @ 0.55p
14:13 35,638 @ 0.55p
13:44 214,824 @ 0.54p
13:29 106,003 @ 0.54p

Valirx Key Personnel

CFO Gerald Desler

Top of Page